Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
4(66.7%)
Phase 1
2(33.3%)
6Total
Phase 2(4)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02615080Phase 2Completed

Safety and Efficacy of CRD007 in Adult Asthma Subjects

Role: lead

NCT02609334Phase 2Completed

RSPR-007 Mannitol Challenge Trial

Role: lead

NCT02517372Phase 1Completed

Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast

Role: lead

NCT01723618Phase 1Completed

Pharmacokinetics of CRD007 in Patients With Abdominal Aorta Aneurisms.

Role: lead

NCT01354184Phase 2Completed

CRD007 for the Treatment of Abdominal Aorta Aneurysm (The AORTA Trial)

Role: lead

NCT01540604Phase 2Completed

CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers

Role: lead

All 6 trials loaded